Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Neuberg Diagnostics Private Limited, is an unlisted private company incorporated on 10 January, 2017. It is classified as a private limited company and is located in Kanchipuram, Tamil Nadu. It's authorized share capital is INR 139.15 cr and the total paid-up capital is INR 94.49 cr.
Neuberg Diagnostics's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 5724.72% over the previous year. At the same time, it's book networth has increased by 1961.36%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
233.94%
-5724.72%
-712.32%
1961.36%
-48.26%
70.79%
-10.19
-3.68
-15.84
-46.19
-21.1
-17.91
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(3)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Catalyst Trusteeship Limited
No. of Loans: 2
Total Amount : 470.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 3
Total Amount : 37.5 cr
Standard Chartered Bank
No. of Loans: 2
Total Amount : 33.7 cr
HDFC Bank Limited
No. of Loans: 11
Total Amount : 26.3 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Gomathy Babu Sadacharam Kulandaivelu
Shareholder
|
00894980 | 7 years |
| Director | Athmanathan Ganesan | 02122660 | 7 years |
| Director | Sandip Chandrakant Shah | 03073470 | 1 years |
| Director | Sujay Ramaprasad | 07629721 | 1 years |
| Kmp | Prakash Sivasamy | <HIDDEN> | 0 years |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Neuberg Diagnostics Mauritius Private Limited | Mauritius | - | - |
| Neuberg Americas Inc. | United States | - | - |
| NEUBERG A. G DIAGNOSTICS PRIVATE LIMITED | Maharashtra | 2018 | ₹ 4.0 Cr |
| NEUBERG EHRLICH LABORATORY PRIVATE LIMITED | Tamil Nadu | 1979 | ₹ 31.8 L |
| NEUBERG AJAY SHAH LABORATORY PRIVATE LIMITED | Maharashtra | 2020 | ₹ 20.4 L |
| NEUBERG ANAND REFERENCE LABORATORY PRIVATE LIMITED | Tamil Nadu | 2022 | ₹ 94.4 L |
| NEUBERG SUPRATECH RAJKOT PRIVATE LIMITED | Gujarat | 2018 | ₹ 1.0 L |
| JEENOMICS LABORATORY PRIVATE LIMITED | Tamil Nadu | 2021 | ₹ 1.5 Cr |
| NEUBERG SAI SRIDEVI DIAGNOSTICS PRIVATE LIMITED | Andhra Pradesh | 2021 | ₹ 12.5 L |
| Labcore Speciality Laboratory | India | - | - |
| Supratech Micropath Laboratory Bhavnagar | India | - | - |
| Neuberg Supratech Amreli Laboratory LLP | India | - | - |
| Neuberg Supratech Jamnagar Laboratory LLP | India | - | - |
| Dr Krunal Neuberg Supratech Labs LLP | India | - | - |
| Neuberg Supratech Mehsana Laboratory LLP | India | - | - |
| Neuberg Supratech Kotgirwar Laboratories LLP | India | - | - |
| Neuberg Labcore Vraj Labs LLP | India | - | - |
| Neuberg Supratech Inspire Diagnotics LLP | India | - | - |
| Neuberg Supratech Prime Diagnotics LLP | India | - | - |
| Neuberg Supratech Science House LLP | India | - | - |
The incorporation date of NEUBERG DIAGNOSTICS PRIVATE LIMITED is 10 January, 2017
The authorized share capital of NEUBERG DIAGNOSTICS PRIVATE LIMITED is INR ₹ 139.2 Cr.
The paid-up capital of NEUBERG DIAGNOSTICS PRIVATE LIMITED is INR ₹ 94.5 Cr.
The registered address of NEUBERG DIAGNOSTICS PRIVATE LIMITED is Plot No. 7, Industrial Estate, Rajiv Gandhi Salai, Perungudi , Chennai, Tamil Nadu Perungudi Saidapet Kanchipuram Tamil Nadu - 600096
The CIN number of NEUBERG DIAGNOSTICS PRIVATE LIMITED is U85300TN2017PTC114099.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
